InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
14
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Farwell Wildon, Directeur Médical. Officer active across 1 company, notably Dyne Therapeutics, Inc.. In total, 19 reports have been recorded. Breakdown: 0 buy · 14 sells. Total volume traded: €750k. History available since 10 December 2021. The latest transaction was filed on 19 August 2024 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Farwell Wildon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
2,060 shares@ US$45.0111.0% of flowCommon StockSEC:0000950170-24-099125:0
1,628 shares@ US$31.276.2% of flowCommon StockSEC:0000950170-24-072168:0
1,956 shares@ US$28.206.7% of flowCommon StockSEC:0000950170-24-062079:0
1,585 shares@ US$25.704.9% of flowCommon StockSEC:0000950170-24-030483:0
8,364 shares@ US$25.8026.0% of flowCommon StockSEC:0000950170-24-029609:0
407 shares@ US$25.001.2% of flowCommon StockSEC:0000950170-24-022242:0
5,493 shares@ US$25.0716.7% of flowCommon StockSEC:0000950170-24-015259:0
100 shares@ US$25.000.3% of flowCommon StockSEC:0000950170-24-008063:0
1,688 shares@ US$10.722.2% of flowCommon StockSEC:0001209191-23-058328:0
82,512 shares0Common StockSEC:0001209191-23-055524:0
1,707 shares@ US$10.412.2% of flowCommon StockSEC:0001209191-23-049362:0
1,698 shares@ US$12.432.6% of flowCommon StockSEC:0001209191-23-037165:0
7,441 shares@ US$13.3312.1% of flowCommon StockSEC:0001209191-23-018979:0
36,000 shares0Common StockSEC:0001209191-22-060969:0
658 shares@ US$14.051.2% of flowCommon StockSEC:0001209191-22-050123:0
668 shares@ US$4.950.4% of flowCommon StockSEC:0001209191-22-037145:0
640 shares@ US$8.730.7% of flowCommon StockSEC:0001209191-22-018533:0
5,617 shares@ US$8.565.7% of flowCommon StockSEC:0001209191-22-015901:0
22,307 shares0Common StockSEC:0001209191-21-069422:0
19 of 19 declarations
About Farwell Wildon
Farwell Wildon is Directeur Médical and Chief Medical Officer at Dyne Therapeutics, Inc. He has 19 filings in total, and across the 19 sampled filings between 2021-12-14 and 2024-08-20, the activity shows sales of EUR 762274 and no purchases; the modal transaction nature is Cession.
